Tielong Liu

760 total citations
29 papers, 574 citations indexed

About

Tielong Liu is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Tielong Liu has authored 29 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Rheumatology, 17 papers in Pulmonary and Respiratory Medicine and 5 papers in Immunology. Recurrent topics in Tielong Liu's work include Bone Tumor Diagnosis and Treatments (22 papers), Sarcoma Diagnosis and Treatment (17 papers) and Musculoskeletal synovial abnormalities and treatments (5 papers). Tielong Liu is often cited by papers focused on Bone Tumor Diagnosis and Treatments (22 papers), Sarcoma Diagnosis and Treatment (17 papers) and Musculoskeletal synovial abnormalities and treatments (5 papers). Tielong Liu collaborates with scholars based in China and United States. Tielong Liu's co-authors include Xinghai Yang, Huabin Yin, Wei Xu, Zhou Wang, Zhipeng Wu, Zhenxi Li, Jianru Xiao, Haifeng Wei, Ting Wang and Wangjun Yan and has published in prestigious journals such as The Lancet Oncology, Biochemical and Biophysical Research Communications and Neurosurgery.

In The Last Decade

Tielong Liu

28 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tielong Liu China 14 365 319 131 116 106 29 574
Nong Lin China 17 266 0.7× 401 1.3× 84 0.6× 106 0.9× 136 1.3× 59 769
Will Aston United Kingdom 19 546 1.5× 709 2.2× 120 0.9× 115 1.0× 545 5.1× 32 1.2k
Takuo Iijima Japan 12 247 0.7× 336 1.1× 81 0.6× 38 0.3× 69 0.7× 16 622
Vaiyapuri P. Sumathi United Kingdom 13 238 0.7× 419 1.3× 49 0.4× 29 0.3× 228 2.2× 40 988
Tatsuyoshi Kojima Japan 11 210 0.6× 272 0.9× 101 0.8× 31 0.3× 76 0.7× 15 504
Georg W. Omlor Germany 18 344 0.9× 247 0.8× 79 0.6× 47 0.4× 316 3.0× 27 846
Louis‐Romée Le Nail France 15 178 0.5× 291 0.9× 52 0.4× 89 0.8× 314 3.0× 83 767
Simone Colangeli Italy 15 493 1.4× 567 1.8× 217 1.7× 56 0.5× 408 3.8× 30 1.1k
Chongqi Tu China 16 126 0.3× 309 1.0× 42 0.3× 111 1.0× 196 1.8× 60 743
Hyun Guy Kang South Korea 18 249 0.7× 393 1.2× 76 0.6× 51 0.4× 387 3.7× 64 894

Countries citing papers authored by Tielong Liu

Since Specialization
Citations

This map shows the geographic impact of Tielong Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tielong Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tielong Liu more than expected).

Fields of papers citing papers by Tielong Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tielong Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tielong Liu. The network helps show where Tielong Liu may publish in the future.

Co-authorship network of co-authors of Tielong Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Tielong Liu. A scholar is included among the top collaborators of Tielong Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tielong Liu. Tielong Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Hui, et al.. (2024). FBXO22 is a potential therapeutic target for recurrent chondrosarcoma. Journal of bone oncology. 46. 100605–100605. 1 indexed citations
2.
Tan, Tao, Ting Wang, Haiyi Gong, et al.. (2022). A chronicle review of new techniques that facilitate the understanding and development of optimal individualized therapeutic strategies for chordoma. Frontiers in Oncology. 12. 1029670–1029670. 2 indexed citations
3.
Liu, Chao, Qi Jia, Haifeng Wei, et al.. (2020). Apatinib in patients with advanced chordoma: a single-arm, single-centre, phase 2 study. The Lancet Oncology. 21(9). 1244–1252. 41 indexed citations
4.
Zhang, Kun, Xin Gao, Tao Wang, et al.. (2019). Tumor derived EDIL3 modulates the expansion and osteoclastogenesis of myeloid derived suppressor cells in murine breast cancer model. Journal of bone oncology. 16. 100238–100238. 11 indexed citations
5.
Jia, Qi, Guanghui Chen, Xinghai Yang, et al.. (2019). Clinical features and prognostic factors of pediatric spine giant cell tumors: report of 31 clinical cases in a single center. The Spine Journal. 19(7). 1232–1241. 21 indexed citations
6.
Gao, Xin, Qi Jia, Xiaopan Cai, et al.. (2019). Recurrence or neurological loss? Resection mode selection for patients with large sacral chordoma: an analysis of prognostic factors and quality of life. Acta Neurochirurgica. 161(12). 2433–2441. 6 indexed citations
7.
Zhao, Chenglong, Dongsheng Wang, Liang Tang, et al.. (2018). Stromal Cell-Derived CCL20 Promotes Tumor Progression and Osteolysis in Giant Cell Tumor of Bone. Cellular Physiology and Biochemistry. 51(5). 2472–2483. 7 indexed citations
8.
Jia, Qi, Chao Liu, Jian Yang, et al.. (2018). Clinical features, treatments and long-term follow-up outcomes of spinal chondroblastoma: report of 13 clinical cases in a single center. Journal of Neuro-Oncology. 140(1). 99–106. 7 indexed citations
9.
Jia, Qi, Zhenhua Zhou, Dan Zhang, et al.. (2017). Surgical management of spinal solitary fibrous tumor/hemangiopericytoma: a case series of 20 patients. European Spine Journal. 27(4). 891–901. 25 indexed citations
10.
Ma, Yifei, Wei Xu, Yiming Li, et al.. (2016). Patient-oncologist alliance and psychosocial well-being in Chinese society strongly affect cancer management adherence with cancer of unknown primary. Psycho-Oncology. 26(7). 991–998. 3 indexed citations
11.
Ma, Yifei, Jun Pan, Wangjun Yan, et al.. (2016). Treatment options and prognosis for repeatedly recurrent giant cell tumor of the spine. European Spine Journal. 25(12). 4033–4042. 11 indexed citations
12.
Ma, Yifei, Wei Xu, Huabin Yin, et al.. (2015). Therapeutic radiotherapy for giant cell tumor of the spine: a systemic review. European Spine Journal. 24(8). 1754–1760. 26 indexed citations
13.
Wang, Jing, Chenglong Zhao, Jianjun Chu, et al.. (2015). Scientific publication in orthopedics journals from Chinese authors: a survey of 10-year survey of the literature. European Spine Journal. 24(8). 1820–1825. 9 indexed citations
14.
Yin, Huabin, Xinghai Yang, Wei Xu, et al.. (2015). Treatment and outcome of primary aggressive giant cell tumor in the spine. European Spine Journal. 24(8). 1747–1753. 32 indexed citations
15.
Xu, Wei, Leqin Xu, Lei Li, et al.. (2014). Prognostic factors of giant cell tumor in mobile spine. Zhonghua guke zazhi. 34(4). 487–493. 1 indexed citations
16.
Xiao, Hui, Tielong Liu, Wangjun Yan, et al.. (2014). The Valuation of Using FDG PET-CT in Detecting Osteoid Osteoma of the Cervical Spine. Journal of Spinal Disorders & Techniques. 28(2). E67–E73. 7 indexed citations
17.
Meng, Tong, Huabin Yin, Bo Li, et al.. (2014). Clinical features and prognostic factors of patients with chordoma in the spine: a retrospective analysis of 153 patients in a single center. Neuro-Oncology. 17(5). 725–732. 69 indexed citations
18.
Wang, Zhou, Huabin Yin, Ting Wang, et al.. (2014). MiR-126-5p regulates osteolysis formation and stromal cell proliferation in giant cell tumor through inhibition of PTHrP. Bone. 66. 267–276. 27 indexed citations
19.
Feng, Dapeng, Xinghai Yang, Shufeng Li, et al.. (2013). Cytotoxic T-Lymphocyte Antigen-4 Genetic Variants and Risk of Ewing's Sarcoma. Genetic Testing and Molecular Biomarkers. 17(6). 458–463. 14 indexed citations
20.
Yin, Huabin, Zhou Wang, Hongyu Yu, et al.. (2013). Clinical characteristics and treatment options for two types of osteoblastoma in the mobile spine: a retrospective study of 32 cases and outcomes. European Spine Journal. 23(2). 411–416. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nong Lin Breakdown of academic impact, for papers by Will Aston Breakdown of academic impact, for papers by Takuo Iijima Breakdown of academic impact, for papers by Vaiyapuri P. Sumathi Breakdown of academic impact, for papers by Tatsuyoshi Kojima Breakdown of academic impact, for papers by Georg W. Omlor Breakdown of academic impact, for papers by Louis‐Romée Le Nail Breakdown of academic impact, for papers by Simone Colangeli Breakdown of academic impact, for papers by Chongqi Tu Breakdown of academic impact, for papers by Hyun Guy Kang
Rankless by CCL
2026